Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2019 11:00 ET | Source: 2Ctech, Inc.

First Clinical Program Initiated Using Nanoparticles to Treat Retinitis Pigmentosa

IRVINE, Calif., April 23, 2019 (GLOBE NEWSWIRE) -- 2Ctech, Inc., a privately-held development stage company focused on the application of nanoparticle technologies for the treatment of retinal...